Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt No Debt
OMCL's Cash to Debt is ranked higher than
73% of the 1620 Companies
in the Global Health Information Services industry.

( Industry Median: 27.13 vs. OMCL: No Debt )
OMCL' s 10-Year Cash to Debt Range
Min: 1.42   Max: No Debt
Current: No Debt

Equity to Asset 0.71
OMCL's Equity to Asset is ranked higher than
76% of the 1591 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCL: 0.71 )
OMCL' s 10-Year Equity to Asset Range
Min: -0.57   Max: 0.78
Current: 0.71

-0.57
0.78
Interest Coverage 289.34
OMCL's Interest Coverage is ranked higher than
63% of the 1074 Companies
in the Global Health Information Services industry.

( Industry Median: 387.00 vs. OMCL: 289.34 )
OMCL' s 10-Year Interest Coverage Range
Min: 44.6   Max: 2381.5
Current: 289.34

44.6
2381.5
F-Score: 5
Z-Score: 5.60
M-Score: -2.75
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.27
OMCL's Operating margin (%) is ranked higher than
78% of the 1594 Companies
in the Global Health Information Services industry.

( Industry Median: 5.57 vs. OMCL: 9.27 )
OMCL' s 10-Year Operating margin (%) Range
Min: -29   Max: 9.27
Current: 9.27

-29
9.27
Net-margin (%) 6.30
OMCL's Net-margin (%) is ranked higher than
76% of the 1592 Companies
in the Global Health Information Services industry.

( Industry Median: 3.70 vs. OMCL: 6.30 )
OMCL' s 10-Year Net-margin (%) Range
Min: -30.86   Max: 20.32
Current: 6.3

-30.86
20.32
ROE (%) 6.87
OMCL's ROE (%) is ranked higher than
68% of the 1553 Companies
in the Global Health Information Services industry.

( Industry Median: 6.88 vs. OMCL: 6.87 )
OMCL' s 10-Year ROE (%) Range
Min: -30.9   Max: 21.02
Current: 6.87

-30.9
21.02
ROA (%) 4.87
OMCL's ROA (%) is ranked higher than
73% of the 1605 Companies
in the Global Health Information Services industry.

( Industry Median: 3.73 vs. OMCL: 4.87 )
OMCL' s 10-Year ROA (%) Range
Min: -47.35   Max: 13.18
Current: 4.87

-47.35
13.18
ROC (Joel Greenblatt) (%) 48.96
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
76% of the 1589 Companies
in the Global Health Information Services industry.

( Industry Median: 31.80 vs. OMCL: 48.96 )
OMCL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -397.58   Max: 144.51
Current: 48.96

-397.58
144.51
Revenue Growth (%) 17.00
OMCL's Revenue Growth (%) is ranked higher than
87% of the 1208 Companies
in the Global Health Information Services industry.

( Industry Median: 6.40 vs. OMCL: 17.00 )
OMCL' s 10-Year Revenue Growth (%) Range
Min: -53.3   Max: 17.5
Current: 17

-53.3
17.5
EBITDA Growth (%) 39.70
OMCL's EBITDA Growth (%) is ranked higher than
92% of the 957 Companies
in the Global Health Information Services industry.

( Industry Median: 7.60 vs. OMCL: 39.70 )
OMCL' s 10-Year EBITDA Growth (%) Range
Min: -14.1   Max: 124.1
Current: 39.7

-14.1
124.1
EPS Growth (%) 64.70
OMCL's EPS Growth (%) is ranked higher than
94% of the 899 Companies
in the Global Health Information Services industry.

( Industry Median: 8.80 vs. OMCL: 64.70 )
OMCL' s 10-Year EPS Growth (%) Range
Min: -69.7   Max: 260.9
Current: 64.7

-69.7
260.9
» OMCL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

OMCL Guru Trades in Q1 2013

Steven Cohen Sold Out
Paul Tudor Jones Sold Out
Jim Simons 29,340 sh (-60.06%)
» More
Q2 2013

OMCL Guru Trades in Q2 2013

Jim Simons 57,943 sh (+97.49%)
» More
Q3 2013

OMCL Guru Trades in Q3 2013

Steven Cohen 14,443 sh (New)
Jim Simons Sold Out
» More
Q4 2013

OMCL Guru Trades in Q4 2013

Paul Tudor Jones 19,574 sh (New)
Joel Greenblatt 72,226 sh (New)
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 New Buy0.04%$22.41 - $25.59 $ 27.2414%72226
Joel Greenblatt 2012-09-30 Sold Out 0.1%$12.79 - $14.97 $ 27.2492%0
Joel Greenblatt 2012-06-30 Add 98.26%0.05%$12.87 - $15.36 $ 27.2492%92061
Joel Greenblatt 2012-03-31 New Buy0.06%$14.22 - $17.85 $ 27.2484%46435
George Soros 2011-12-31 Sold Out 0.0037%$13.05 - $17.05 $ 27.2476%0
George Soros 2011-09-30 Add 25%$13.2 - $17.11 $ 27.2476%15500
George Soros 2011-06-30 New Buy$13.28 - $15.61 $ 27.2482%12400
Joel Greenblatt 2011-03-31 Sold Out $12.97 - $15.2 $ 27.2495%0
Mario Gabelli 2011-03-31 Sold Out $12.97 - $15.2 $ 27.2495%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 40.90
OMCL's P/E(ttm) is ranked lower than
57% of the 1124 Companies
in the Global Health Information Services industry.

( Industry Median: 23.60 vs. OMCL: 40.90 )
OMCL' s 10-Year P/E(ttm) Range
Min: 8.94   Max: 795.88
Current: 40.9

8.94
795.88
P/B 2.78
OMCL's P/B is ranked higher than
56% of the 1505 Companies
in the Global Health Information Services industry.

( Industry Median: 2.45 vs. OMCL: 2.78 )
OMCL' s 10-Year P/B Range
Min: 0.96   Max: 14.79
Current: 2.78

0.96
14.79
P/S 2.56
OMCL's P/S is ranked lower than
55% of the 1660 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. OMCL: 2.56 )
OMCL' s 10-Year P/S Range
Min: 0.94   Max: 5.54
Current: 2.56

0.94
5.54
PFCF 28.08
OMCL's PFCF is ranked lower than
54% of the 874 Companies
in the Global Health Information Services industry.

( Industry Median: 19.60 vs. OMCL: 28.08 )
OMCL' s 10-Year PFCF Range
Min: 8   Max: 342.2
Current: 28.08

8
342.2
EV-to-EBIT 25.10
OMCL's EV-to-EBIT is ranked lower than
53% of the 1286 Companies
in the Global Health Information Services industry.

( Industry Median: 17.42 vs. OMCL: 25.10 )
OMCL' s 10-Year EV-to-EBIT Range
Min: 6.3   Max: 424.9
Current: 25.1

6.3
424.9
PEG 0.88
OMCL's PEG is ranked higher than
82% of the 604 Companies
in the Global Health Information Services industry.

( Industry Median: 2.00 vs. OMCL: 0.88 )
OMCL' s 10-Year PEG Range
Min: 0.5   Max: 42.93
Current: 0.88

0.5
42.93
Shiller P/E 79.54
OMCL's Shiller P/E is ranked lower than
67% of the 617 Companies
in the Global Health Information Services industry.

( Industry Median: 29.33 vs. OMCL: 79.54 )
OMCL' s 10-Year Shiller P/E Range
Min: 15.61   Max: 299.13
Current: 79.54

15.61
299.13

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 46.97
OMCL's Price/Net Current Asset Value is ranked lower than
83% of the 664 Companies
in the Global Health Information Services industry.

( Industry Median: 10.90 vs. OMCL: 46.97 )
OMCL' s 10-Year Price/Net Current Asset Value Range
Min: 2.99   Max: 324
Current: 46.97

2.99
324
Price/Tangible Book 6.22
OMCL's Price/Tangible Book is ranked lower than
59% of the 1230 Companies
in the Global Health Information Services industry.

( Industry Median: 4.00 vs. OMCL: 6.22 )
OMCL' s 10-Year Price/Tangible Book Range
Min: 1.76   Max: 13.28
Current: 6.22

1.76
13.28
Price/DCF (Projected) 1.98
OMCL's Price/DCF (Projected) is ranked higher than
50% of the 743 Companies
in the Global Health Information Services industry.

( Industry Median: 1.50 vs. OMCL: 1.98 )
OMCL' s 10-Year Price/DCF (Projected) Range
Min: 1.13   Max: 8.67
Current: 1.98

1.13
8.67
Price/Median PS Value 1.16
OMCL's Price/Median PS Value is ranked higher than
62% of the 1501 Companies
in the Global Health Information Services industry.

( Industry Median: 1.10 vs. OMCL: 1.16 )
OMCL' s 10-Year Price/Median PS Value Range
Min: 0.25   Max: 1.93
Current: 1.16

0.25
1.93
Price/Peter Lynch Fair Value 1.62
OMCL's Price/Peter Lynch Fair Value is ranked higher than
60% of the 368 Companies
in the Global Health Information Services industry.

( Industry Median: 1.50 vs. OMCL: 1.62 )
OMCL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 1.32   Max: 23.38
Current: 1.62

1.32
23.38
Price/Graham Number 3.34
OMCL's Price/Graham Number is ranked lower than
59% of the 903 Companies
in the Global Health Information Services industry.

( Industry Median: 2.20 vs. OMCL: 3.34 )
OMCL' s 10-Year Price/Graham Number Range
Min: 1.59   Max: 8.12
Current: 3.34

1.59
8.12
Earnings Yield (Greenblatt) 4.00
OMCL's Earnings Yield (Greenblatt) is ranked higher than
52% of the 1328 Companies
in the Global Health Information Services industry.

( Industry Median: 5.40 vs. OMCL: 4.00 )
OMCL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 15.9
Current: 4

0.2
15.9
Forward Rate of Return (Yacktman) 31.13
OMCL's Forward Rate of Return (Yacktman) is ranked higher than
93% of the 1009 Companies
in the Global Health Information Services industry.

( Industry Median: 5.44 vs. OMCL: 31.13 )
OMCL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6.2   Max: 43.2
Current: 31.13

-6.2
43.2

Business Description

Industry: Application Software » Health Information Services
Compare:CERN, CTRX, ATHN, MDRX, AH » details
Traded in other countries:OC9.Germany
Omnicell, Inc., formerly Omnicell Technologies, Inc., is a Delaware corporation. The Company provides automation and business information solutions enabling healthcare systems to streamline medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Its automation, analytics and medication adherence solutions enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and enhance patient safety, reduce medication errors, reduce operating costs, improve workflow and increase operational efficiency. Approximately 2,700 hospitals and 6,000 institutional and retail pharmacies utilize the company's products and services. The Company's business is organized into two operating business segments: Acute Care, which primarily includes products and services sold to hospital customers, offers analytics and reporting software for pharmacists and materials managers to manage inventory flow, tracking and optimization and Non-Acute Care, which primarily includes products and services sold to customers outside of the hospital setting and manufactures proprietary medication dispensing systems and related products for use by medication prescription providers: primarily institutional pharmacies servicing long-term care and correctional facilities. The Company is subject to taxes in the United States and other foreign jurisdictions.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide